Imunosupresiva - inhibitory TNF alfa II.
Institut klinické a experimentální medicíny
Deadline
19 Oct 2026
Contract value
CZK 72m
Category
Medical equipment and pharmaceuticals
How big is this contract?
The same figure measured twice, because the answer differs depending on where you bid from.
Against 8 comparable contracts open across Europe
lower quarter
middle half
upper quarter
Against 8 open under the same code in Czechia
lower quarter
middle half
upper quarter
On the small side of comparable contracts.
Can your company bid for this?
Paste a website. We read what the company does and score it against this tender. No account.
The record
As published. The notice text stays with the publisher.
Buyer
Institut klinické a experimentální medicíny
Country
Czechia
Procedure
Contract notice, standard
Category
33652300 - Medical equipment and pharmaceuticals
Contract value
CZK 72m
Published
20 Sept 2026
Deadline
19 Oct 2026
Reference
646821-2026
Open tenders like this one
Ranked by what the notices are about, not by matching words in the title.
Selektivní Imunosupresiva - Eculizumab IV.
CzechiaInstitut klinické a experimentální medicíny
Closes: 19 Oct 2026
LP s obsahem zolbetuximabu 2026 - sdružený nákup
CzechiaFakultní nemocnice Olomouc
Closes: 21 Oct 2026
Vedolizumab II.
CzechiaÚstřední vojenská nemocnice - Vojenská fakultní nemocnice Praha
Closes: 4 Nov 2026